𝐖𝐞 𝐰𝐢𝐥𝐥 𝐛𝐞 𝐚𝐭 𝐄𝐋𝐑𝐈𝐆 𝐃𝐫𝐮𝐠 𝐃𝐢𝐬𝐜𝐨𝐯𝐞𝐫𝐲 𝟐𝟎𝟐𝟔!

For its 20th edition, the programme spans the full discovery pipeline, from target identification and validation to enabling technologies. Lysosomal and mitochondrial targets are increasingly central across therapeutic areas, and reliable data on them starts with access to native organelles.

At ORIA Bioscience, we deliver ready-to-assay, functional organelles at scale. Come discuss what they can unlock for your targets!

📍 𝐎𝐜𝐭 𝟏𝟒 𝐭𝐨 𝟏𝟓, 𝐄𝐱𝐂𝐞𝐋 𝐋𝐨𝐧𝐝𝐨𝐧, 𝐔𝐊
✔️ 𝐁𝐨𝐨𝐭𝐡 𝐁𝟏𝟖
✔️ 𝐏𝐨𝐬𝐭𝐞𝐫 𝟔𝟏: 𝘈 𝘔𝘦𝘥𝘪𝘶𝘮-𝘛𝘩𝘳𝘰𝘶𝘨𝘩𝘱𝘶𝘵 𝘖𝘳𝘨𝘢𝘯𝘦𝘭𝘭𝘦-𝘉𝘢𝘴𝘦𝘥 𝘛𝘰𝘰𝘭𝘣𝘰𝘹 𝘵𝘰 𝘐𝘯𝘵𝘦𝘳𝘳𝘰𝘨𝘢𝘵𝘦 𝘋𝘪𝘷𝘦𝘳𝘴𝘦 𝘋𝘳𝘶𝘨 𝘛𝘢𝘳𝘨𝘦𝘵𝘴 𝘈𝘤𝘳𝘰𝘴𝘴 𝘛𝘩𝘦𝘳𝘢𝘱𝘦𝘶𝘵𝘪𝘤 𝘈𝘳𝘦𝘢𝘴

Meet us at the booth, or reach out to them directly to set up a 1:1 meeting.